Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema Model

<table>Increase in edema volume (%) in anti-inflammatory activity evaluation of ufasomes containing dexamethasone (0.5% w/w), plain gel “and” marketed formulation using the method of acute edema inhibition produced by carrageenin injection (5 rats per group) (ANOVA, F test).</table>

Journal of Pharmaceutics

fig9

Figure 9

Figure 9: Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema Model 

Figure 9 | Ufasomes Mediated Cutaneous Delivery of Dexamethasone: Formulation and Evaluation of Anti-Inflammatory Activity by Carrageenin-Induced Rat Paw Edema Model 